Clinical Significance of Lung-RADS Category 3 lesions in the National Lung Screening Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Significance of Lung-RADS Category 3 lesions in the National Lung Screening Trial
J Thorac Oncol 2021 Mar 12;[EPub Ahead of Print], DH Han, F Duan, Y Wu, JM Goo, HY Kim, EF PatzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.